US Rep. Gaetz’s Diagnosis of What’s Driving Insulin Costs Misses the Root Cause
Kaiser Health News
APRIL 22, 2022
Drug pricing experts said there’s no question that insulin’s list price (the amount charged to consumers and their health plans) has risen over the past decade. However, the pharmaceutical industry disagrees with this assessment. In 2018, the annual number of new diagnoses had risen to about 27 million.
118 
Let's personalize your content